This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Labopharm Inc., Universitéde Montreal. Active years: 1997-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1999
Title: Innovations of Louis Cartilier
Introduction
Louis Cartilier is a notable inventor based in Beaconsfield, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug delivery systems. With a total of 3 patents, his work focuses on enhancing the efficacy and efficiency of drug release mechanisms.
Latest Patents
One of Cartilier's latest patents is titled "Substituted amylose as a matrix for sustained drug release." This invention describes a pharmaceutical sustained release tablet for oral administration, made from a compressed blend of at least two dry powders, including a pharmaceutical drug and a sustained release matrix. The matrix is composed of substituted amylose, which is prepared by reacting amylose with an organic substituent in a basic medium. This innovative approach allows for a controlled and sustained release of the drug, achieving a remarkable close-to-linear profile with a release time ranging from 9 to 20 hours.
Another significant patent is "Cross-linked amylose as a binder/disintegrant in tablets." This invention focuses on the manufacture of solid dosage units, specifically utilizing powders of cross-linked amylose as tablet binders and disintegrants. The specific degree of cross-linking enhances the performance of these powders in pharmaceutical applications.
Career Highlights
Throughout his career, Louis Cartilier has worked with prominent organizations, including Labopharm Inc. and Université de Montréal. His experience in these institutions has contributed to his expertise in pharmaceutical innovations and drug delivery systems.
Collaborations
Cartilier has collaborated with notable individuals in his field, including Mircea Alexandru Mateescu and Yves Dumoulin. These collaborations have further enriched his research and development efforts.
Conclusion
Louis Cartilier's contributions to pharmaceutical innovations, particularly in drug release mechanisms, highlight his role as a significant inventor in the industry. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and healthcare providers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile